GMA-161
GMA-161 is a humanized IgG1 antibody that targets Fcγ receptor III (CD16). GMA-161 has the potential for the study of autoimmune disorders. The isotype control for GMA-161 can refer to Human IgG1 kappa, Isotype Control.
Product Specifications
UNSPSC
12352203
Target
Fc Receptor (FcR)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
96.61
References & Citations
[1]Flaherty MM, et al. Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice. Toxicol Sci. 2012 Jan;125 (1) :299-309.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-1650R-APC-Cy5.5 100 µL
Phospho-P53 (Ser392) Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
K0220107 1.0 µg DNA
C1QL3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
MBS1062631-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O9:H4 Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details MBS1062631-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O9:H4 Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details MBS1062631-03 0.02 mg (Yeast)
Recombinant Escherichia coli O9:H4 Phosphatidylserine decarboxylase proenzyme (psd)
Sign In for Pricing
View Details